Mitochondrial control of fuel switching via carnitine biosynthesis
Authors:
- Christopher AugerCAChristopher Auger
- Hiroshi NishidaHNHiroshi Nishida
- Bo YuanBYBo Yuan
- Guilherme Martins SilvaGSGuilherme Martins Silva
- Daisuke KatohDKDaisuke Katoh
- Dandan WangDWDandan Wang
- Melia Granath-PaneloMGMelia Granath-Panelo
- Jihoon ShinJSJihoon Shin
- Anthony VerkerkeAVAnthony Verkerke
- Alexander BanksABAlexander Banks
Preprint
Abstract
Metabolic adaptation to environmental changes, such as fasting and cold exposure, involves a dynamic shift in fuel utilization from glucose to fatty acid oxidation, a process that relies on carnitine-mediated fatty acid oxidation in mitochondria. While dietary sources of animal origin (e.g., red meat) contribute to the carnitine pool, de novo carnitine synthesis from trimethyllysine (TML) is essential, particularly for those whose dietary sources are vegetables and fruits that contain negligible amounts of carnitine. However, the molecular pathway of de novo carnitine synthesis and its physiological significance remain poorly understood. Here, we showed that SLC25A45 is a mitochondrial TML carrier that controls de novo carnitine biosynthesis in vivo. Genetic loss of SLC25A45 results in systemic carnitine and acylcarnitine deficiency, leading to impaired fatty acid oxidation and thermogenesis during cold adaptation, while promoting glucose catabolism. Notably, Slc25a45-deficient mice maintained a high respiratory exchange ratio and impaired lipid mobilization following treatment with a GLP1 receptor agonist (GLP-1RA), rendering them resistant to GLP-1RA-induced adipose tissue loss. Together, the present study identifies SLC25A45 as a regulatory checkpoint in fuel switching during adaptation, with implications for systemic energy balance and response to GLP-1RA-mediated anti-obesity therapy.Keywords
All Related Versions
- Published version: Science, 391 (6786), eady5532.
This publication has 46 references indexed in Scilit:
- Impaired Transport of Nucleotides in a Mitochondrial Carrier Explains Severe Human Genetic DiseasesACS Chemical Biology, 2012
- PPARγ agonists Induce a White-to-Brown Fat Conversion through Stabilization of PRDM16 ProteinCell Metabolism, 2012
- Thyroid hormone-regulated gene expression in juvenile mouse liver: identification of thyroid response elements using microarray profiling and in silico analysesBMC Genomics, 2011
- Role of carnitine in diseaseNutrition & Metabolism, 2010
- Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21Cell Metabolism, 2007
- Epithelial-Specific Cre/lox Recombination in the Developing Kidney and Genitourinary TractJournal of the American Society of Nephrology, 2002
- Thyroid hormone controls carnitine status through modifications of γ-butyrobetaine hydroxylase activity and gene expressionCellular and Molecular Life Sciences, 2002
- Carnitine biosynthesis in mammalsBiochemical Journal, 2002
- Thyroid Hormone Regulates Carnitine Palmitoyltransferase Iα Gene Expression through Elements in the Promoter and First IntronJournal of Biological Chemistry, 2000
- Decreased Tissue Distribution of l-Carnitine in Juvenile Visceral Steatosis MiceThe Journal of Pharmacology and Experimental Therapeutics, 1999